Recent advances in the treatment of Gram-positive infections
- 1 December 2004
- journal article
- review article
- Published by Elsevier in Drug Discovery Today: Therapeutic Strategies
- Vol. 1 (4) , 455-460
- https://doi.org/10.1016/j.ddstr.2004.08.015
Abstract
No abstract availableThis publication has 37 references indexed in Scilit:
- In Vitro Antimicrobial Activity of Doripenem, a New CarbapenemAntimicrobial Agents and Chemotherapy, 2004
- Daptomycin: Another Novel Agent for Treating Infections Due to Drug‐Resistant Gram‐Positive PathogensClinical Infectious Diseases, 2004
- Worldwide assessment of dalbavancin activity and spectrum against over 6,000 clinical isolatesDiagnostic Microbiology and Infectious Disease, 2004
- In vitro antibacterial activity of the peptide deformylase inhibitor BB-83698Journal of Antimicrobial Chemotherapy, 2004
- The GlycylcyclinesDrugs, 2004
- AcrB Multidrug Efflux Pump of Escherichia coli : Composite Substrate-Binding Cavity of Exceptional Flexibility Generates Its Extremely Wide Substrate SpecificityJournal of Bacteriology, 2003
- In vitro activity of tigecycline (GAR-936), a novel glycylcycline, against vancomycin-resistant enterococci and staphylococci with diminished susceptibility to glycopeptidesJournal of Antimicrobial Chemotherapy, 2003
- Genetic strategies for antibacterial drug discoveryNature Reviews Genetics, 2003
- The Design of Leadlike Combinatorial LibrariesAngewandte Chemie International Edition in English, 1999
- Fluoroquinolone Resistance inStreptococcus pneumoniaeNew England Journal of Medicine, 1999